Kristi A. Leonard, Ph.D.
Affiliations: | 2000 | State University of New York, Buffalo, Buffalo, NY, United States |
Google:
"Kristi Leonard"Mean distance: 9.1
Parents
Sign in to add mentor| Michael R. Detty | grad student | 2000 | SUNY Buffalo | |
| (The design and synthesis of novel chalcogenopyrylium dyes as agents for photodynamic therapy.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Gege C, Albers M, Kinzel O, et al. (2020) Optimization and biological evaluation of thiazole-bis-amide inverse agonists of RORγt. Bioorganic & Medicinal Chemistry Letters. 30: 127205 |
| Steeneck C, Gege C, Kinzel O, et al. (2020) Discovery and optimization of new oxadiazole substituted thiazole RORγt inverse agonists through a bioisosteric amide replacement approach. Bioorganic & Medicinal Chemistry Letters. 30: 127174 |
| Tanis VM, Venkatesan H, Cummings MD, et al. (2019) 3-Substituted Quinolines as RORγt Inverse Agonists. Bioorganic & Medicinal Chemistry Letters |
| Gege C, Cummings MD, Albers M, et al. (2018) Identification and biological evaluation of thiazole-based inverse agonists of RORγt. Bioorganic & Medicinal Chemistry Letters |
| Barbay JK, Cummings MD, Abad M, et al. (2017) 6-Substituted quinolines as RORγt inverse agonists. Bioorganic & Medicinal Chemistry Letters |
| Shook BC, Chakravarty D, Barbay JK, et al. (2013) Substituted thieno[2,3-d]pyrimidines as adenosine A2A receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 23: 2688-91 |
| Subasinghe NL, Khalil E, Travins JM, et al. (2012) Design and synthesis of polyethylene glycol-modified biphenylsulfonyl-thiophene-carboxamidine inhibitors of the complement component C1s. Bioorganic & Medicinal Chemistry Letters. 22: 5303-7 |
| Shook BC, Rassnick S, Wallace N, et al. (2012) Design and characterization of optimized adenosine Aâ‚‚A/Aâ‚ receptor antagonists for the treatment of Parkinson's disease. Journal of Medicinal Chemistry. 55: 1402-17 |
| Raboisson P, Manthey CL, Chaikin M, et al. (2006) Novel potent and selective αvβ3αvβ5 integrin dual antagonists with reduced binding affinity for human serum albumin European Journal of Medicinal Chemistry. 41: 847-861 |
| Leonard KA, Hall JP, Nelen MI, et al. (2000) A selenopyrylium photosensitizer for photodynamic therapy related in structure to the antitumor agent AA1 with potent in vivo activity and no long-term skin photosensitization. Journal of Medicinal Chemistry. 43: 4488-98 |